Oxford Covid vaccine safe for adults
By AFP
November 20, 2020
PARIS: A leading Covid-19 vaccine candidate has shown to safely produce a robust immune response in healthy older adults, its British makers said on Thursday as it released its phase 2 trial results. The vaccine, developed by the University of Oxford and AstraZeneca, produced fewer side effects in people aged 56 and over than in younger people -- a significant finding given that Covid-19 disproportionately causes severe illness among seniors.
-
Hailee Steinfeld Spills Her 'no-phone' Rule With Husband Josh Allen -
Bowen Yang Gets Honest About Post SNL Life: 'It’s An Adjustment' -
Charlize Theron Delivers Strong Message At 2026 Winter Olympics Opening Ceremony -
Lil Jon Reacts To Son Nathan Smith's Death: 'Devastated' -
Bianca Censori Reveals Where She And Kanye West Stand On Having Children Together -
Taylor Swift Hypes Olympic Athletes In Surprise Video Message -
Timothy Busfield Charged With Four Counts Of Child Sexual Abuse -
Amy Schumer Explains Why Her Sudden Photo Surge Is ‘not A Cry For Help’ -
Kanye West First Contacted Bianca Censori While In Marriage To Kim Kardashian? -
Travis Kelce Reveals What His Nieces Really Do When He, Taylor Swift Visit -
Lola Young Makes Career Announcement After Stepping Back From Touring -
Priyanka Chopra Shares Heartfelt Message For Nick Jonas -
Spotify, Major Labels File $13b Lawsuit Over Alleged Music Scraping -
Travis Kelce Opens Up About Being Backup Plan For His Nieces -
Winter Olympics 2026: Chinese Robot Dance Goes Viral In Milan -
Jessica Biel Urged To Divorce Justin Timberlake?